AXQ Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,400
Closed -$150K 536
2024
Q1
$150K Buy
+20,400
New +$150K 0.04% 550
2023
Q2
Sell
-15,964
Closed -$91K 390
2023
Q1
$91K Sell
15,964
-52,175
-77% -$297K 0.04% 452
2022
Q4
$688K Buy
+68,139
New +$688K 0.48% 65